# Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion

> **NCT07552610** · NA · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 868 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Large Vessel Occlusion
- Thrombectomy
- Neutrophil Extracellular Trap Formation

## Interventions

- **DRUG:** Sivelestat sodium
- **DRUG:** Placebo
- **PROCEDURE:** Endovascular Thrombectomy

## Key facts

- **NCT ID:** NCT07552610
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 868 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552610, "Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07552610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*